PHENERGAN VC W/ CODEINE
LOE Approachingcodeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride
NDAORALSYRUP
Approved
Jan 1952
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Phenergan VC with Codeine is a combination oral syrup containing codeine phosphate (antitussive), phenylephrine hydrochloride (decongestant), and promethazine hydrochloride (antihistamine/anticholinergic). It is indicated for symptomatic relief of cough and upper respiratory congestion associated with allergies, colds, or minor respiratory infections. The formulation works synergistically to suppress cough reflex, reduce nasal/sinus congestion, and minimize allergic symptoms.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%) signals transition phase requiring defensive commercial strategies and possible right-sizing of promotional infrastructure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings and LOE trajectory signal limited near-term hiring or career advancement opportunity on this legacy brand. Positions available would focus on defensive commercial execution, generic transition management, and regulatory compliance rather than growth-oriented innovation roles.
Brand ManagerProduct Manager
Worked on PHENERGAN VC W/ CODEINE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.